Adverse Pregnancy Outcomes Using The International Association of the Diabetes and Pregnancy Study Groups Criteria: Glycemic Thresholds and Associated Risks
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To compare the risks of selected adverse pregnancy outcomes among untreated women who met The International Association of the Diabetes and Pregnancy Study Groups (IADPSG)-defined glucose criteria at two different thresholds. METHODS: A retrospective cohort study of women tested for gestational diabetes mellitus (GDM) with the 75-g 2-hour glucose tolerance test (GTT) who delivered a live singleton neonate. Data of women who were treated because they met institutional criteria defining GDM (at least two GTT results greater than or equal to fasting 100 mg/dL, 1-hour 195 mg/dL, and 2-hour 160 mg/dL) were excluded. The data of the remaining women were analyzed in three groups. The prevalence of selected adverse pregnancy outcomes was compared for those with no GDM ("no GDM," n=7,943); those at least one of whose results were fasting 92-94 mg/dL, 1-hour 180-190 mg/dL, or 2-hour 153-161 mg/dL ("GDM-1," n=771); and those at least one of whose results were greater than or equal to fasting 95 mg/dL, 1-hour 191 mg/dL, or 2-hour 162 mg/dL ("GDM-2," n=1,121). RESULTS: Of the 9,835 women, 1,892 (19.2%) met criteria for GDM, of whom 771 (40.8%) were categorized as GDM-1 and 1,121 (59.2%) GDM-2. After adjustment for confounders, women with GDM-2 were at significantly greater risk for preeclampsia or eclampsia, preterm delivery, primary cesarean delivery, shoulder dystocia, higher birth weight, ponderal index, large for gestational age, transient tachypnea, and neonatal hypoglycemia than women without GDM. Only birth weight and large for gestational age were significantly greater in the GDM-1 compared with the no GDM group. CONCLUSION: Fewer adverse outcomes are found at lower levels of the IADPSG-defined glucose intolerance spectrum. Determining whether these patients will benefit from treatment will require a randomized controlled trial. LEVEL OF EVIDENCE: II.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“Fortyfive years elapsed between the time of presentation of criteria defining GDM in the United States(18) and a randomized controlled trial that established that a subset of women identified by these criteria for GDM would benefit from treatment.(28) The current data are presented in the hope that they will serve as…”
BackgroundPreventing overdiagnosis: how to stop harming the healthy
Moynihan, R., Doust, J., & Henry, D. (2012) · BMJ · doi:10.1136/bmj.e3502 · Cited by 675
Duran, A., Sáenz, S., Torrejón, M. J., Bordiú, E., del Valle, L., Galindo, M., Perez, N., Herraiz, M. A., Izquierdo, N., Rubio, M. A., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0179 · Cited by 335
collaborators, O. B. O. T. A. D., O’Sullivan, E. P., Avalos, G., O’Reilly, M., Dennedy, M. C., Gaffney, G., & Dunne, F. (2011) · Diabetologia · doi:10.1007/s00125-011-2150-4 · Cited by 307
Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy
Sacks, D. A., Greenspoon, J. S., Abu-Fadil, S., Henry, H. M., Wolde-Tsadik, G., & Yao, J. F. F. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90580-4 · Cited by 210 · cited 1×
“In 1995 we published the results of a 75-g, 2-hour GTT administered to 3,505 unselected pregnant women.(17) Following O’Sullivan’s model(18) but without antecedent glucose screening, we defined GDM as at least two GTT results equaling or exceeding the mean62 standard deviation for fasting, 1- and 2-hour values, rounde…”
MethodSelf-citation(2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31829c3e64 · Cited by 124
Bodmer-Roy, S., Morin, L., Cousineau, J., & Rey, E. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31826994ec · Cited by 97
Ethridge, J. K., Catalano, P. M., & Waters, T. P. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000412 · Cited by 95
Cited by
Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis
Ye, W., Luo, C., Huang, J., Li, C., Liu, Z., & Liu, F. (2022) · BMJ · doi:10.1136/bmj-2021-067946 · Cited by 1,073
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Garnæs, K. K., Mørkved, S., Salvesen, Ø., & Moholdt, T. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002079 · Cited by 161
Griffith, R. J., Alsweiler, J., Moore, A. E., Brown, S., Middleton, P., Shepherd, E., & Crowther, C. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012394.pub3 · Cited by 149
Brown, F. M., & Wyckoff, J. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0922-z · Cited by 122
“A retrospective cohort study investigated the impact of different glycemic thresholds on outcomes in women screened with a 75-g 2-h OGTT [54].”
Background
Metadata
- Authors
- Sacks, D. A., Black, M. H., Li, X., Montoro, M. N., & Lawrence, J. M.
- Venue
- Obstetrics & Gynecology
- Published
- 2015-07
- Volume
- 126
- Issue
- 1
- Pages
- 67-73
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W1260354277
- Cited by
- 66
- References
- 12
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adverse Pregnancy Outcomes Using The International Association of the Diabetes and Pregnancy Study Groups Criteria: Glycemic Thresholds and Associated Risks. https://app.cochat.ai/papers/10.1097/aog.0000000000000865
- The paper
- Sacks, D. A., Black, M. H., Li, X., Montoro, M. N., & Lawrence, J. M. (2015). Adverse Pregnancy Outcomes Using The International Association of the Diabetes and Pregnancy Study Groups Criteria: Glycemic Thresholds and Associated Risks. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000000865
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.